Severe hypertension in pregnancy: Hydralazine or labetalol A randomized clinical trial
Objective The objective was to compare the safety and efficacy of intravenous labetalol and intravenous hydralazine for acutely lowering blood pressure in pregnancy. Study design Two hundred women with severe hypertension in pregnancy were randomized to receive hydralazine (5 mg
6 min read